Showing results (191-200 of 230) with videos related to
Sort By:
Pageof 23
Immunity|May 17, 2018
Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T CellsBertram Bengsch, Takuya Ohtani, Omar Khan, et al.Cancer Immunology Research|April 30, 2014
Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicityLiang-Chuan S Wang, Albert Lo, John Scholler, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2022
Monitoring Therapeutic Response to Anti-FAP CAR T Cells Using [18F]AlF-FAPI-74Iris K Lee, Estela Noguera-Ortega, Zebin Xiao, et al.Cancer Immunology Research|May 5, 2019
Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non-Small Cell Lung CancerShaun M O'Brien, Astero Klampatsa, Jeffrey C Thompson, et al.Biorxiv : the Preprint Server for Biology|April 24, 2023
Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumorsZebin Xiao, Leslie Todd, Li Huang, et al.Nature Communications|August 22, 2023
Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumorsZebin Xiao, Leslie Todd, Li Huang, et al.Transplantation|July 23, 2011
Targeted endothelial delivery of nanosized catalase immunoconjugates protects lung grafts donated after cardiac deathGerhard Preissler, Florian Loehe, Ines V Huff, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2014
Multifactorial T-cell hypofunction that is reversible can limit the efficacy of chimeric antigen receptor-transduced human T cells in solid tumorsEdmund K Moon, Liang-Chuan Wang, Douglas V Dolfi, et al.Proceedings of the National Academy of Sciences of the United States of America|March 21, 2024
IL7 increases targeted lipid nanoparticle-mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translationCaitlin M Tilsed, Barzan A Sadiq, Tyler E Papp, et al.Proceedings of the National Academy of Sciences of the United States of America|February 13, 2009
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domainsCarmine Carpenito, Michael C Milone, Raffit Hassan, et al.Pageof 23